PROFESSIONAL EDITION

The largest community of pharma leaders

Admin

2806 articles

Robert Dempsey Joins iVeena Board of Directors

SALT LAKE CITY--(BUSINESS WIRE)--iVeena Delivery Systems (iVeena), a clinical stage biopharmaceutical company with developmental products in cataract and cornea, announces the appointment of Robert...

Progenity Strengthens Executive Leadership Team with Appointment of Sami Shihabi as Chief Commercial Officer

SAN DIEGO--(BUSINESS WIRE)--Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, announced the...

Quotient Sciences Appoints Claes Glassell as Non-Executive Chairman of Board of Directors

NOTTINGHAM, England--(BUSINESS WIRE)--Quotient Sciences, the innovative drug development and manufacturing organization, today announces the appointment of Claes Glassell as non-executive chairman of its board...

John McCabe Joins Oncorus, Inc. as Chief Financial Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oncorus, Inc., a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today announced the appointment of John...

RAPT Therapeutics Strengthens Board with Addition of Veteran Biotechnology Executive Wendye Robbins, M.D.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company developing oral small molecules for oncology and inflammatory diseases, today announced the...

AVROBIO Appoints Holly May as Chief Commercial Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVROBIO, Inc. (NASDAQ: AVRO) (the “Company”), a Phase 2 clinical-stage gene therapy company, today announced the appointment of Holly May, MBA, a...